Literature DB >> 11307093

Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial.

A S Rosemurgy1, F M Serafini, B R Zweibel, T J Black, B T Kudryk, H J Nord, S E Goode.   

Abstract

We report herein the results of extended follow-up of an expanded randomized clinical trial comparing transjugular intrahepatic portosystemic shunt (TIPS) to 8 mm prosthetic H-graft portacaval shunt as definitive treatment for variceal bleeding due to portal hypertension. Beginning in 1993, through this trial, both shunts were undertaken as definitive therapy, never as a "bridge to transplantation." All patients had bleeding esophageal/gastric varices and failed or could not undergo sclerotherapy/banding. Patients were excluded from randomization if the portal vein was occluded or if survival was hopeless. Failure of shunting was defined as inability to shunt, irreversible shunt occlusion, major variceal rehemorrhage, hepatic transplantation, or death. Median follow-up after each shunt was 4 years; minimum follow-up was 1 year. Patients undergoing placement of either shunt were very similar in terms of age, sex, cause of cirrhosis, Child's class, and circumstances of shunting. Both shunts provided partial portal decompression, although the portal vein-inferior vena cava pressure gradient was lower after H-graft portacaval shunt (P < 0.01). TIPS could not be placed in two patients. Shunt stenosis/occlusion was more frequent after TIPS. After TIPS, 42 patients failed (64%), whereas after H-graft portacaval shunt 23 failed (35%) (P < 0.01). Major variceal rehemorrhage, hepatic transplantation, and late death were significantly more frequent after TIPS (P < 0.01). Both TIPS and H-graft portacaval shunt achieve partial portal decompression. TIPS requires more interventions and leads to more major rehemorrhage, irreversible occlusion, transplantation, and death. Despite vigilance in monitoring shunt patency, TIPS provides less optimal outcomes than H-graft portacaval shunt for patients with portal hypertension and variceal bleeding.

Entities:  

Mesh:

Year:  2000        PMID: 11307093     DOI: 10.1016/s1091-255x(00)80107-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  13 in total

1.  Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy.

Authors:  A J Sanyal; A M Freedman; V A Luketic; P P Purdum; M L Shiffman; J Tisnado; P E Cole
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

Review 2.  Small-diameter portocaval shunt vs. transjugular intrahepatic portosystemic shunt for portal hypertension.

Authors:  E E Zervos; A S Rosemurgy
Journal:  Adv Surg       Date:  1997

3.  Partial portal decompression for variceal hemorrhage.

Authors:  K Johansen
Journal:  Am J Surg       Date:  1989-05       Impact factor: 2.565

4.  Small-diameter portacaval H-graft for variceal hemorrhage.

Authors:  E B Rypins; I J Sarfeh
Journal:  Surg Clin North Am       Date:  1990-04       Impact factor: 2.741

5.  Differential effects on portal and effective hepatic blood flow. A comparison between transjugular intrahepatic portasystemic shunt and small-diameter H-graft portacaval shunt.

Authors:  A S Rosemurgy; E E Zervos; S E Goode; T J Black; B R Zwiebel
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

6.  Small-diameter H-graft portacaval shunt reduces portal flow yet maintains effective hepatic blood flow.

Authors:  E E Zervos; S E Goode; A S Rosemurgy
Journal:  Am Surg       Date:  1998-01       Impact factor: 0.688

7.  Immediate and long-term portal hemodynamic consequences of small-diameter H-graft portacaval shunt.

Authors:  E E Zervos; S E Goode; A S Rosemurgy
Journal:  J Surg Res       Date:  1998-01       Impact factor: 2.192

8.  A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices.

Authors:  A S Rosemurgy; S E Goode; B R Zwiebel; T J Black; P G Brady
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

9.  The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.

Authors:  M Rössle; K Haag; A Ochs; M Sellinger; G Nöldge; J M Perarnau; E Berger; U Blum; A Gabelmann; K Hauenstein
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

10.  Long-term follow-up of poor-risk patients undergoing small-diameter portacaval shunts.

Authors:  R C Darling; D M Shah; B B Chang; P N Thompson; R P Leather
Journal:  Am J Surg       Date:  1992-09       Impact factor: 2.565

View more
  19 in total

1.  TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial.

Authors:  Alexander S Rosemurgy; Emmanuel E Zervos; Whalen C Clark; Donald P Thometz; Thomas J Black; Bruce R Zwiebel; Bruce T Kudryk; L Shane Grundy; Larry C Carey
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

2.  Should stent-grafts replace bare stents for primary transjugular intrahepatic portosystemic shunts?

Authors:  Manfred Cejna
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

3.  Current role of surgery in portal hypertension.

Authors:  Sujoy Pal
Journal:  Indian J Surg       Date:  2011-12-13       Impact factor: 0.656

4.  H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals.

Authors:  Alexander S Rosemurgy; Mark Bloomston; Whalen C Clark; Donald P Thometz; Emmanuel E Zervos
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

Review 5.  Current management of portal hypertension.

Authors:  Andrew S Wright; Layton F Rikkers
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

6.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

Review 7.  Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Authors:  Sith Siramolpiwat
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 8.  Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management.

Authors:  Erwin Biecker
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

Review 9.  Current state of portosystemic shunt surgery.

Authors:  Martin Wolff; Andreas Hirner
Journal:  Langenbecks Arch Surg       Date:  2003-03-29       Impact factor: 3.445

10.  Conventional predictors of survival poorly predict and significantly underpredict survival after H-graft portacaval shunts.

Authors:  Sarah M Cowgill; Donald Thometz; Whalen Clark; Desiree Villadolid; Elizabeth Carey; Daphne Pinkas; Emmanuel Zervos; Alexander Rosemurgy
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.